Altamira Therapeutics LTD Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
SCHEDULE 13D/A: Thomas Meyer Boosts Stake in Altamira Therapeutics, Now Holding 18.9% of Common Shares
Thomas Meyer, a significant shareholder, increased his beneficial ownership in Altamira Therapeutics Ltd. to 18.9% after receiving 1,053,392 common shares as a bonus.